Journal of Prevention and Infection Control Open Access

  • ISSN: 2471-9668
  • Journal h-index: 6
  • Journal CiteScore: 1.11
  • Journal Impact Factor: 1.04
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Short Communication - (2023) Volume 9, Issue 3

Klebsiella: An Emerging Threat in Healthcare
Freud Carl*
 
Department of Science, University of California, USA
 
*Correspondence: Freud Carl, Department of Science, University of California, USA, Email:

Received: 30-Aug-2023, Manuscript No. IPJPIC-23-17937; Editor assigned: 01-Sep-2023, Pre QC No. IPJPIC-23-17937 (PQ); Reviewed: 15-Sep-2023, QC No. IPJPIC-23-17937; Revised: 20-Sep-2023, Manuscript No. IPJPIC-23-17937 (R); Published: 27-Sep-2023, DOI: 10.36648/2471-9668-9.3.27

Introduction

Klebsiella, a genus of gram-negative bacteria, has gained prominence as a healthcare-associated pathogen due to its ability to develop antibiotic resistance and cause a range of infections. This research article provides an in-depth review of Klebsiella, covering its historical context, taxonomy, virulence factors, antibiotic resistance mechanisms, clinical manifestations, epidemiology, diagnostic methods, treatment options, and current research developments. The increasing threat posed by multidrug-resistant Klebsiella strains necessitates a comprehensive understanding of this pathogen and concerted efforts to combat its spread. Klebsiella species are among the most common gram-negative bacteria associated with healthcare-acquired infections. Their capacity to develop antibiotic resistance and their role in a variety of infections, including pneumonia and urinary tract infections, have made Klebsiella a significant focus of research and public health concern. Understanding the historical context of Klebsiella is essential to appreciate its evolution as a healthcare-associated pathogen. Klebsiella species were initially identified as part of the normal human microbiota but have since emerged as important opportunistic pathogens. Klebsiella is a genus within the family encompassing several species with varying virulence factors and antibiotic resistance profiles. The taxonomic classification of Klebsiella and its subspecies is a dynamic area of research. Klebsiella strains possess numerous virulence factors that enable them to cause infections.

Description

These factors include capsule polysaccharides, lipopolysaccharides, fimbriae, and various enzymes that contribute to their pathogenicity. One of the most alarming aspects of Klebsiella infections is their capacity to develop antibiotic resistance. Klebsiella pneumoniae, in particular, is associated with the emergence of carbapenem-resistant strains, often harboring extended-spectrum. Klebsiella can cause a wide range of infections, including urinary tract infections, pneumonia, bloodstream infections, and wound infections. The clinical presentation varies depending on the site of infection and the virulence of the strain involved. Klebsiella infections are a significant concern in healthcare settings, particularly in intensive care units. The ability of these bacteria to persist in the hospital environment and their propensity for healthcare-associated outbreaks pose unique challenges for infection control. Accurate and timely diagnosis of Klebsiella infections is essential for appropriate patient management and infection control. Diagnostic methods include culture and susceptibility testing, molecular methods, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The management of Klebsiella infections is complicated by the rising prevalence of antibiotic resistance. Empirical treatment often involves broad-spectrum antibiotics, but targeted therapy should be guided by susceptibility testing. Combination therapy and alternative treatment options are sometimes necessary in the face of multidrug-resistant strains. Ongoing research on Klebsiella focuses on understanding the molecular mechanisms of antibiotic resistance, developing new treatment strategies, and improving infection control measures. Strategies to combat carbapenem- resistant Klebsiella and other multidrug-resistant pathogens are of paramount importance [1-4].

Conclusion

Klebsiella is an emerging threat in healthcare, with its multidrug- resistant strains posing a considerable challenge to infection control and patient care. A comprehensive understanding of the taxonomy, virulence factors, antibiotic resistance mechanisms, clinical manifestations, and epidemiology of Klebsiella infections is vital for addressing this public health concern. As research continues to elucidate the complexities of Klebsiella infections, the development of effective prevention, treatment, and control strategies remains essential to combat this formidable pathogen and safeguard patient health in healthcare settings.

Acknowledgement

None.

Conflict Of Interest

None.

References

Citation: Carl F (2023) Klebsiella: An Emerging Threat in Healthcare. J Prevent Infect Control. 9:27.

Copyright: © 2023 Carl F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.